[Nd(4-PYA)_3(H_2O)_2]_n的合成及其晶体结构

3-(4-吡啶基)丙烯酸(4-HPYA)和Nd(NO3)3通过水热法合成了一种新的一维链状配位聚合物[Nd(4-PYA)3(H2O)2]n(1),其结构经IR,元素分析和X-射线单晶衍射表征。1属三斜晶系,P-1空间群,晶胞参数:a=0.829 23(13)nm,b=1.272 60(2)nm,c=1.435 00(12)nm,α=112.371(2)°,β=98.856(3)°,γ=100.239(2)°,V=1.336 6(3)nm3,Mr=660.72,Z=2,Dc=1.642 g.cm-3,F(000)=662,μ=2.002mm-1,R1=0.052 3,wR2=0.141 9。1通过分子间氢键作用将一维链紧密堆积成三维网状结构。     

包含银的Keggin型锗钼酸盐[NH_4]_2[Ag(H_2O)(H_2PDCA)]_2[α-GeMo_(12)O_(40)]·12H_2O（英文）

利用常规水溶液方法合成了一种有机-无机杂化的包含银的Keggin型锗钼酸盐[NH_4]_2[Ag(H_2O)(H_2PDCA)]_2[α-GeMo_(12)O_(40)]·12H_2O(1),并通过元素分析、红外光谱和单晶X射线衍射等对其进行了表征.X射线晶体学研究表明化合物1的分子结构由1个典型的Keggin结构[α-GeMo12O40]~(4-)聚阴离子、2个[Ag(H_2O)(H_2PDCA)]~+配离子、2个NH+4离子和12个结晶水分子构成.值得注意的是在[α-GeMo_(12)O_(40)]~(4-)单元中,锗原子呈现出立方体几何配位构型,这归结于与锗原子相连的每个氧原子都无序地排列在两个位置.有趣的是,每个[α-GeMo_(12)O_(40)]~(4-)多阴离子通过4个[Ag(H_2O)(H_2PDCA)]~+桥配离子与4个[α-GeMo_(12)O_(40)]~(4-)多阴离子相连构筑了二维层状结构.此外,我们还在室温下研究了化合物1的电化学性质.     

Synthesis, Crystal Structure and Luminescence Property of [Co(hmz)_2(H_2O)_4]·2H_2O

A new mononuclear Co(II) complex, [Co(hmz)2(H2O)4]·2H2O, has been synthesized by the reaction of Co(CH3COO)2·4H2O with 1-(4-hydroxyphenyl)-5-mercaptotetrazole (Hhmz). It crystallizes in the monoclinic system, space group P21/n with a = 13.502(5), b = 6.718(3), c = 13.972(6) , β = 117.532(4)o, V = 1123.9(8) 3, Z = 2, M r = 553.45, F(000) = 570, Dc = 1.635 g/cm3, μ = 1.008 mm–1, the final R = 0.0272 and wR = 0.0684 for 2194 observed reflections (I > 2σ(I)). The Co(II) is six-coordinated by two nitrogen atoms from two hmz–1 ligands and four water molecules, forming an octahedral geometry. The intermolecular hydrogen bonding and offset-panel π-π stacking interactions between the adjacent molecules extend the compound into a three- dimensional supramolecular framework. The title compound emits strong blue fluorescent light (λem(max) = 427 nm) at room temperature and is red-shifted compared with free ligand Hhmz (λem(max) = 342 nm).     

硫酸镉无机层和原位反应生成的吡啶基四氮唑有机配体构筑的两个层-柱状三维无机-有机杂化材料:合成和表征

以硫酸镉、叠氮化钠和4-氰基吡啶或3-氰基吡啶为反应物,在水热条件下,通过原位反应分别得到了2个基于硫酸根离子和5-(4-吡啶基)四氮唑(4-Hptz)或5-(3-吡啶基)四氮唑(3-Hptz)配体的,具有三维层-柱状框架结构的无机-有机杂化材料,即[Cd₂(H₂O)(OH)(SO₄)(4-ptz)]_n(1)和[Cd₂(OH)(SO₄)(3-ptz)]_n(2)。通过元素分析、红外光谱、热重分析以及单晶和粉末X-射线衍射分析对它们的组成和结构进行了表征。在配合物1和2的结构中,每个镉(Ⅱ)离子的配位数均为6,处于扭曲的八面体配位环境中,SO₄^2-和OH-阴离子连接镉(Ⅱ)离子扩展形成碱式硫酸镉的二维无机阳离子层结构[Cd₂(H₂O)(OH)(SO₄)]_nⁿ⁺(1)或[Cd₂(OH)(SO₄)]_nⁿ⁺(2),相邻的二维无机阳离子层间再通过4-ptz^-(1)或3-ptz^-(2)进一步柱连接,形成三维层-柱状结构的无机-有机杂化框架结构。室温下的固体荧光实验表明,在350nm的光激发下,配合物1和2分别在481和489nm处出现强烈的荧光发射。     

硫酸镉无机层和原位反应生成的吡啶基四氮唑有机配体构筑的两个层-柱状三维无机-有机杂化材料:合成和表征

以硫酸镉、叠氮化钠和4-氰基吡啶或3-氰基吡啶为反应物,在水热条件下,通过原位反应分别得到了2个基于硫酸根离子和5-(4-吡啶基)四氮唑(4-Hptz)或5-(3-吡啶基)四氮唑(3-Hptz)配体的,具有三维层-柱状框架结构的无机-有机杂化材料,即[Cd₂(H₂O)(OH)(SO₄)(4-ptz)]_n(1)和[Cd₂(OH)(SO₄)(3-ptz)]_n(2)。通过元素分析、红外光谱、热重分析以及单晶和粉末X-射线衍射分析对它们的组成和结构进行了表征。在配合物1和2的结构中,每个镉(Ⅱ)离子的配位数均为6,处于扭曲的八面体配位环境中,SO₄^2-和OH^-阴离子连接镉(Ⅱ)离子扩展形成碱式硫酸镉的二维无机阳离子层结构[Cd₂(H₂O)(OH)(SO₄)]_nⁿ+(1)或[Cd₂(OH)(SO₄)]_nⁿ+(2),相邻的二维无机阳离子层间再通过4-ptz^-(1)或3-ptz^-(2)进一步柱连接,形成三维层-柱状结构的无机-有机杂化框架结构。室温下的固体荧光实验表明,在350 nm的光激发下,配合物1和2分别在481和489 nm处出现强烈的荧光发射。     

1H-3-(3-吡啶基)-5-(3'-吡啶基)-1,2,4-三唑的钴(Ⅱ)配合物的合成、晶体结构、热稳定性及配体的DFT计算

合成了一个多功能的配体1H-3-(3-吡啶)-5-(3'-吡啶)-1,2,4-三唑(3,3'-Hbpt, 1)并得到了配体的晶体结构。运用DFT理论计算了配体的最优构型、优势构象和电荷分布。在此基础上,水热合成了一个配位化合物:[Co(3,3'-Hbpt)₂(H₂O)₄]·(ad)·6H₂O(2)(ad=己二酸), 结构分析表明配合物2是零维单核化合物,它的三维超分子结构是由分子间氢键连接而成,其中包含着由游离的己二酸分子填充的矩形孔道。值得注意的是,配体在配合物中的几何结构和构象与理论计算的结果一致。另外,利用热重分析研究了配合物2的热稳定性。     

1H-3-(3-吡啶基)-5-(3'-吡啶基)-1,2,4-三唑的钴(Ⅱ)配合物的合成、晶体结构、热稳定性及配体的DFT计算

合成了一个多功能的配体1H-3-(3-吡啶)-5-(3'-吡啶)-1,2,4-三唑(3,3'-Hbpt,1)并得到了配体的晶体结构,运用DFT理论计算了配体的最优构型、优势构象和电荷分布。在此基础上,水热合成了一个配位化合物:[Co(3,3'-Hbpt)₂(H₂O)₄]·(ad)·6H₂O(2)(ad=己二酸),结构分析表明配合物2是零维单核化合物,它的三维超分子结构是由分子间氢键连接而成,其中包含着由游离的己二酸分子填充的矩形孔道。值得注意的是,配体在配合物中的几何结构和构象与理论计算的结果一致。另外,利用热重分析研究了配合物2的热稳定性。     

合成3-羟基-2-(4-吡啶基)-1H-茚-1-酮的工艺改进

以邻苯二甲酸酐和4-甲基吡啶为起始原料,正十二烷为溶剂,氯化锌为催化剂,于190℃反应24 h合成了抗癌药物瓦他拉尼的关键中间体——3-羟基-2-(4-吡啶基)-1H-茚-1-酮,收率90.6%,其结构经1H NMR,IR和MS确证。     

Synthesis and Crystal Structure of Ni_3(admt)_6(NCS)_6·C_2H_5OH·2H_2O

1　INTRODUCTIONCoordination compounds with 1 ,2 ,4 triazole as a ligand have interesting fea tures,notonly because ofthe very interesting magnetic propertiesofthese complex es,but also because ofrich modes ofcoordination〔1〕.Particularly,the coordinationbehavioroftriazoletowardsa numberoftransition metalthiocyanatesshowsremark abledifferences〔2 - 6〕.On unsubstitution at N4 ,thetriazole ring hasmonodentate,1 ,2 and 2 ,4 bridging forms.These three modes were all observed in the Ni( II)…     

离子化合物｛[2-(3′-pyridyl)benzimidazoleH_2]~(2+)·[SbCl_4]~-·Cl~-｝_4的水热合成、晶体结构及抑菌活性

0引言锑的化合物很早就作为药物使用,如酒石酸锑钾用于治疗血吸虫病,葡萄糖酸锑钠用于抗黑热病。在研究治疗血吸虫病药物的同时,发现了氨羧类锑化合物的抗肿瘤活性[1]。一些锑的配合物和化合物具有一定的生物活性[2],如酵母甘露聚糖和甘露聚糖衍生物锑的配合物对利什曼原虫有治疗作用[3],锑的配合物还可作高效杀虫灭菌剂。因此,对锑化合物的研究越来越受到人们的重视。苯并咪唑及其衍生物是一类生物活性很强的广谱抑菌剂[4],也是一些重要生物分子的基本部分。它作为含氮的富电子体系,可与含空轨道的金属原子形成配合物,并具有生物活性,这方…     

Metabolic study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to the enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in vitro in human bronchial epithelial cells using chiral capillary electrophoresis

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) with one chiral center at the carbinol is a major metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). As tobacco specific N-nitrosamines (TSNAs), NNK and NNAL are the most pulmonary carcinogens in tobacco products and smoke. In this paper, a chiral CE method modified with highly sulfated β-cyclodextrin (S-β-CD) was developed to investigate the stereoselective formation of NNAL from NNK in vitro in normal human bronchial epithelial (NHBE) cells. Combined with solid phase extraction (SPE) of the cell samples, NNK and NNAL enantiomers were baseline separated under the proposed CE conditions, with satisfactory recoveries (72.5-113% for NNK and (±)-NNAL) and low limits of detection (LOD, 2.5-3 μg/mL for NNK and (±)-NNAL). The cytotoxicity of NNK in NHBE cells was investigated through the cell counting kit (CCK) assay and proved to be highly dependent on the NNK's concentration. The metabolic results obtained from CE analysis demonstrated that NNK was preferentially metabolized to (+)-NNAL through carbonyl reduction. Meanwhile, the ratio of [(+)-NNAL]/[(-)-NNAL] was independent of NHBE cells' incubation time with NNK, but could be changed according to the original incubation concentration of NNK. This chiral CE method could be useful for the study on toxicology and metabolic transformations of related TSNAs.     

1-(4-硝基苯基)-3-(5-硝基-2-吡啶)-三氮烯的合成及其与汞(Ⅱ)的显色反应研究

合成了 1 -(4 -硝基苯基 ) -3 -(5-硝基 -2 -吡啶 ) -三氮烯 ,并研究了它与汞(Ⅱ )的显色反应。在TritonX -1 0 0的存在下 ,pH1 1 2的Na2 B4 O7-NaOH缓冲溶液中 ,试剂与汞生成 2∶1型桔黄色配合物 ,在 4 3 8nm和 52 5nm处分别有一正一负两个吸收波峰 ,用双峰双波长测定 ,其表观摩尔吸光系数为 2 1× 1 0 5L·mo1 1·cm 1,Hg2 +的浓度在 0～ 2 80 μg/L范围内符合比耳定律。成功地测定了人发和尿液中微量的汞。     

Synthesis and Crystal Structure of （2S,5S）-1-Aza-2-（2-pyridyl）-3-oxa-4,4-diphenylbicyclo [3.3.0] Octane

1 INTRODUCTION The catalytic asymmetric synthesis has been a challenging subject in organic synthesis. The deve- lopment of efficient enantioselective catalysts appli- cable to a wide range of carbon-carbon bond form- ing reactions represents a pivotal …     

1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯对银的显色反应及研究

合成了1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯(ABCPDT),并研究了AB-CPDT与银的显色反应。在Na2B4O7-NaOH缓冲溶液(pH 10.0)介质中,Triton X-100存在下试剂与Ag生成络合物(1∶1)。络合物在550 nm处有最大吸收峰,络合物的表观摩尔吸光系数为1.65×105L.mol-1.cm-1,Ag质量浓度在0~0.48μg/mL范围内符合比耳定律。方法已用于回收定影液中银的测定。     

Synthesis,Characterization and Biological Activities ofN-Acyl-3-(3-pyridyl)-5-aryl-pyrazoles

Ten novel N-acyl-3-(3-pyridyl)-5-aryl-pyrazoles were synthesized by Claisen condensation of the aryl methyl ketones with ethyl nicotinate, the cyclization with hydrazine hydrate and the N-acylation with acyl chloride in turn. The structures of all the compounds synthesized were confirmed by means of Fourier transform infrared(FTIR), ¹H NMR, mass spectroscopy and elemental analysis. The biological activities of the title compounds were examined by disc diffusion method against Escherichia coli, Staphylococcus aureus, Pyricularia oryzae and Rhizoctnia solani. All the N-acyl-3-(3-pyridyl)-5-aryl-pyrazoles exhibited a certain degree of antibacterial and antifungal activities. Comparatively, compounds 3c and 3d exhibited much significant antibacterial and antifungal activities than the other pyrazole derivatives.     

1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯的合成及其与铜的显色反应

报道了新显色剂1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯的合成及其与铜的显色反应.在表面活性剂NP-10存在下,pH11.0的Na2B4O7-NaOH缓冲溶液中,该试剂与铜发生显色反应,生成31型的红色配合物,配合物的最大吸收峰位于535mm,表观摩尔吸光系数为1.43×105L·mol-1·cm-1.Cu2+质量浓度在0～480μg/L范围内符合比尔定律.用拟定方法测定合金中微量铜,结果令人满意.     

1-偶氮苯-3-(5-氰-2-吡啶)-三氮烯的合成及其与锌的显色反应

报道了新显色剂1-偶氮苯-3-(5-氰-2-吡啶)-三氮烯的合成。在pH 10~12的硼砂-氢氧化钠缓冲溶液中,NP-40表面活性剂存在下,该试剂与锌发生显色反应,生成3∶1的红色配合物。配合物的最大吸收峰位于530 nm,表观摩尔吸光系数为1.52×105L.mol-1.cm-1。Zn2+质量浓度在0~0.48 mg/L范围内遵守比尔定律。用该法测定人发中微量锌,结果令人满意。     

Synthesis and structure of hydrazones obtained from hydrazides of [5-(4-pyridyl)-1,3,4-oxadiazol-2-ylthio]acetic or 2-[5-(4-pyridyl)-1,3,4-oxadiazol-2-ylthio]propionic acids

It has been shown by¹H NMR spectroscopy that hydrazones obtained by the condensation of hydrazides of [5-4-pyridyl)-1,3,4-oxadiazol-2-ylthio] acetic or 2-[5-(2-pyridyl)-1,3,4-oxadiazol-2-ylthio]propionic acids with aldehydes, ketones, and -dicarbonyl compounds exist in DMSO solution as a mixture of stereoisomeric forms.Institute of Chemistry, Vilnius LT-2600, Lithuania. Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 7, pp. 966–971, July, 2000.     

新显色剂1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯的合成及其与镉的显色反应

报道了新显色剂1-偶氮苯-3-(5-氰基-2-吡啶)-三氮烯的合成及其与镉的显色反应。在表面活性剂OP存在下,pH 11.0的Na2B4O7-NaOH缓冲溶液中,该试剂与镉发生显色反应,生成4∶1型的红色配合物。配合物的最大吸收峰位于525 nm,表观摩尔吸光系数为2.02×105L.mol-1.cm-1。Cd2+的线性范围为1~0.6μg/mL。用拟定方法测定废水中微量镉,结果令人满意。